Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.

Initial cell surface expression of the pre-B cell receptor induces proliferation. After 2 to 5 divisions, however, large pre-BII (Fraction C') cells exit cell cycle to become resting, small pre-BII cells (Fraction D). The mechanism by which pre-BII cells exit cell cycle, however, is currently unclear. The checkpoint at the Fraction C'-D transition is critical for immunoglobulin light chain gene recombination and to prevent malignant transformation into acute lymphoblastic leukemia. Here we demonstrate that inducible activation of pre-B cell receptor signaling induces cell-cycle exit through up-regulation of the transcriptional repressor BCL6. Inducible activation of BCL6 downstream of the pre-B cell receptor results in transcriptional repression of MYC and CCND2. Hence, pre-B cell receptor-mediated activation of BCL6 limits pre-B cell proliferation and induces cellular quiescence at the small pre-BII (Fraction D) stage.

[1]  Sebastian Herzog,et al.  BCL6 enables Ph+ acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition , 2011, Nature.

[2]  M. Mandal,et al.  Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression , 2010, Molecular and Cellular Biology.

[3]  Marjolein J. W. de Bruijn,et al.  Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway. , 2010, Blood.

[4]  A. Melnick,et al.  BCL6 is critical for the development of a diverse primary B cell repertoire , 2009, The Journal of experimental medicine.

[5]  N. Heisterkamp,et al.  Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function , 2009, The Journal of experimental medicine.

[6]  M. Farrar,et al.  BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. , 2009, Blood.

[7]  R. DePinho,et al.  SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway , 2008, Nature Immunology.

[8]  Christopher B. Miller,et al.  BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.

[9]  Ryan T. Phan,et al.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.

[10]  M. Reth,et al.  Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B Cells , 2003, The Journal of experimental medicine.

[11]  M. Schrappe,et al.  Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia , 2003, Nature.

[12]  H. Jäck,et al.  Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Staudt,et al.  BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. , 2000, Immunity.

[14]  K Offit,et al.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. , 1993, Science.

[15]  J. Koziol,et al.  The expression of the Ig H chain repertoire in developing bone marrow B lineage cells. , 1991, Journal of immunology.

[16]  H. Jäck,et al.  Transcriptome analysis in primary B lymphoid precursors following induction of the pre-B cell receptor. , 2008, Molecular immunology.

[17]  M. Reth,et al.  The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion , 2003, Nature Immunology.

[18]  R. Hardy,et al.  B cell development pathways. , 2001, Annual review of immunology.